Year-end Sale % OFF 
Abstract
All patients with paragangliomas and pheochromocytomas should ideally be tested for germline mutations in SDH. While there are well identified pathogenic variants associated with hereditary pheochromocytoma and paraganglioma syndromes, with increasing frequency of genetic testing, newer variants in known genetic locations are being identified.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
